Only EU countries endorse ‘Crimea annexation’ term at Riga summit — declaration
Russian Baltic Fleet marines perform naval landing from world's biggest hovercraft
Russia continues attempts to rescue Russians from captivity in Ukraine — Kremlin
Proton failure to affect commercial launches, says Russian space center director
Russia,Turkey plan to sign intergovernmental agreement on Turkish Stream by end of June
Russia’s Olympic Sochi to host 2017 Winter World Military GamesSports May 22, 21:54
Russia will take tough position in case Ukraine refuses to repay debts — PM MedvedevRussia May 22, 21:47
Russia continues attempts to rescue Russians from captivity in Ukraine — KremlinRussia May 22, 21:41
Russian lawmaker: West is growing disappointed with UkraineWorld May 22, 21:32
Azerbaijan set to strengthen cooperation with European Union — TuskWorld May 22, 21:22
Russia’s Finance Ministry sues tycoon PotaninRussia May 22, 21:10
Protective duties may be imposed on import of dairy products to Russia — ministryEconomy May 22, 20:50
Ukraine Contact Group, Subgroups to have next round of talks June 2World May 22, 20:25
DPR expects Kiev to cancel amendments to law on Donbas after Contact Group meetingWorld May 22, 20:16
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.